NO995900L - Retrovirale vektorpartikler dannet i et baculovirus- ekspresjonssystem - Google Patents

Retrovirale vektorpartikler dannet i et baculovirus- ekspresjonssystem

Info

Publication number
NO995900L
NO995900L NO995900A NO995900A NO995900L NO 995900 L NO995900 L NO 995900L NO 995900 A NO995900 A NO 995900A NO 995900 A NO995900 A NO 995900A NO 995900 L NO995900 L NO 995900L
Authority
NO
Norway
Prior art keywords
expression system
retroviral vector
particles formed
baculovirus expression
vector particles
Prior art date
Application number
NO995900A
Other languages
English (en)
Other versions
NO995900D0 (no
Inventor
Alan John Kingsman
Ian Martin Jones
Original Assignee
Oxford Biomedica Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oxford Biomedica Ltd filed Critical Oxford Biomedica Ltd
Publication of NO995900D0 publication Critical patent/NO995900D0/no
Publication of NO995900L publication Critical patent/NO995900L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/14011—Baculoviridae
    • C12N2710/14111—Nucleopolyhedrovirus, e.g. autographa californica nucleopolyhedrovirus
    • C12N2710/14141—Use of virus, viral particle or viral elements as a vector
    • C12N2710/14144—Chimeric viral vector comprising heterologous viral elements for production of another viral vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/13011—Gammaretrovirus, e.g. murine leukeamia virus
    • C12N2740/13041—Use of virus, viral particle or viral elements as a vector
    • C12N2740/13043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/13011—Gammaretrovirus, e.g. murine leukeamia virus
    • C12N2740/13051—Methods of production or purification of viral material
    • C12N2740/13052—Methods of production or purification of viral material relating to complementing cells and packaging systems for producing virus or viral particles
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/15011—Lentivirus, not HIV, e.g. FIV, SIV
    • C12N2740/15041—Use of virus, viral particle or viral elements as a vector
    • C12N2740/15043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/15011—Lentivirus, not HIV, e.g. FIV, SIV
    • C12N2740/15051—Methods of production or purification of viral material
    • C12N2740/15052—Methods of production or purification of viral material relating to complementing cells and packaging systems for producing virus or viral particles

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)

Abstract

En sammensetning er beskrevet. Sammensetningen omfatter minst en baculoviral komponent og minst en retroviral komponent, hvor den retrovirale komponent kan pakkes inn i en retroviral partikkel.
NO995900A 1997-06-04 1999-12-02 Retrovirale vektorpartikler dannet i et baculovirus- ekspresjonssystem NO995900L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9711578.6A GB9711578D0 (en) 1997-06-04 1997-06-04 Novel retroviral vector production systems
PCT/GB1998/001626 WO1998055640A1 (en) 1997-06-04 1998-06-04 Retroviral vector particles produced in a baculovirus expression system

Publications (2)

Publication Number Publication Date
NO995900D0 NO995900D0 (no) 1999-12-02
NO995900L true NO995900L (no) 2000-02-04

Family

ID=10813571

Family Applications (1)

Application Number Title Priority Date Filing Date
NO995900A NO995900L (no) 1997-06-04 1999-12-02 Retrovirale vektorpartikler dannet i et baculovirus- ekspresjonssystem

Country Status (11)

Country Link
EP (1) EP0986649A1 (no)
JP (1) JP2002510204A (no)
KR (1) KR20010013332A (no)
CN (1) CN1259171A (no)
AU (1) AU741764B2 (no)
CA (1) CA2289491A1 (no)
GB (1) GB9711578D0 (no)
IL (1) IL132359A0 (no)
NO (1) NO995900L (no)
NZ (1) NZ500936A (no)
WO (1) WO1998055640A1 (no)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000073424A1 (en) * 1999-05-28 2000-12-07 Mount Sinai School Of Medicine A novel baculovirus/adenovirus hybrid vector for the rescue, production and titration of high-capacity adenovirus amplicon vectors
EP1399585B1 (en) 2000-10-23 2008-02-20 Gen-Probe Incorporated Compositions and methods for detecting human immunodeficiency virus 2 (hiv-2)
TWI477602B (zh) 2006-02-09 2015-03-21 Educational Foundation Jichi Medical Univ Novel viral vector
US9333249B2 (en) 2006-02-09 2016-05-10 Educational Foundation Jichi Medical University Recombinant baculovirus vaccine
GB0702695D0 (en) * 2007-02-12 2007-03-21 Ark Therapeutics Ltd Production of vectors
WO2009088256A2 (ko) 2008-01-09 2009-07-16 Konkuk University Industrial Cooperation Corp 배큘로바이러스-기반 백신

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1309680C (en) * 1987-07-24 1992-11-03 David Harano Airlift insect cell culture
WO1989009271A1 (en) * 1988-03-21 1989-10-05 Viagene, Inc. Recombinant retroviruses
WO1991019803A1 (en) * 1990-06-19 1991-12-26 Applied Biotechnology, Incorporated Self assembled, defective, nonself-propagating viral particles
GB9510272D0 (en) * 1995-05-22 1995-07-19 Isis Innovation Retroviral vectors

Also Published As

Publication number Publication date
AU741764B2 (en) 2001-12-06
KR20010013332A (ko) 2001-02-26
NO995900D0 (no) 1999-12-02
GB9711578D0 (en) 1997-07-30
IL132359A0 (en) 2001-03-19
EP0986649A1 (en) 2000-03-22
WO1998055640A1 (en) 1998-12-10
CN1259171A (zh) 2000-07-05
AU7780098A (en) 1998-12-21
JP2002510204A (ja) 2002-04-02
NZ500936A (en) 2001-11-30
CA2289491A1 (en) 1998-12-10

Similar Documents

Publication Publication Date Title
ATE224183T1 (de) Konditionierende shampoozusammensetzung
DE69515891D1 (de) Verbundstoff und saugfähiges wäschestück mit diesem verbundstoff
DE69801976D1 (de) Zusammensetzung und Gegenstand mit verbessertem Druckverformungsrest
HUP0004929A3 (en) Cellulosic based polymers, detergent and laundry additive composition containing the same
DE69106714D1 (en) Hypoglykämische hydroxyharnstoffderivate.
DE69002805D1 (de) Coextrusionsfaehige klebstoffe und damit hergestellte gegenstaende.
EP0714738A4 (en) SUPPORTING DISC FOR SCISSORS AND SCISSORS USING THE SAME
GB2285806B (en) Alkali-treated bagasse,and its preparation and uses
ATE301329T1 (de) Partikel
ID29052A (id) Turunan-turunan 3,3-biarilpiperidina dan 2,2-biarilmorfolina
AP9801289A0 (en) Proc ss fo prep ring ,4-di ydroxypy-ridine and 2,4-dihydroxy-3-nitropyridine
MX240950B (es) Estructura absorbente en articulo absorbente, que compende un material superabsorbente parcialmente neutralizado, y articulo absorbente que comprende la estructura absorbente.
AU1915399A (en) Cs-1 peptidomimetics, compositions and methods of using the same
FR2753978B1 (fr) Composition thermodurcissable, ses utilisations et preforme souple depliable comprenant cette composition
NO995900L (no) Retrovirale vektorpartikler dannet i et baculovirus- ekspresjonssystem
DK1101053T3 (da) Dobbelt ringtætning i ét stykke
AU8876591A (en) Indole-3-methanamines useful as anti-diabetic, anti-obesity and anti-atherosclerotic agents
PT929299E (pt) 1,2,3,4-tetra-hidro-2-dibenzofuranaminas e 2-aminociclo-hepta ¬b| benzofuranos substituidos
ZA969402B (en) Novel oligopeptides, the preparation and use thereof.
EP0827082A4 (en) SEMICONDUCTOR MEMORY WITH ARITHMETIC FUNCTION AND USE OF THE SAME IN A PROCESSOR
ZA9610929B (en) Polymeric particulate materials and compositions containing them.
AU7310191A (en) Photoluminescent materials, particularly for coating various surfaces, and uses thereof
ES1026518Y (es) Cubo con escurridor y mocho perfeccionado.
Kang et al. Combined effects of hypoxia and hydrogen sulfide on early developmental stages of white shrimp Metapenaeus monoceros
IL116164A0 (en) Proteins having fibrinolytic and thrombin-inhibiting properties

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application